411 filings
Page 16 of 21
UPLOAD
s9003
26 Aug 19
Letter from SEC
12:00am
F-3
twaa8a
22 Aug 19
Shelf registration (foreign)
5:25pm
6-K
si27 uriu3kwi
31 Jul 19
Therapix Biosciences Announces Canadian Product LicenseĀ Issuance for TheraPEA (CannAmideā¢), a Non-Opiate Based Pain Management Supplement
4:03pm
6-K
6fv 5u8wd201qx
23 Jul 19
Therapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a
4:05pm
6-K
80vz6 ehxfrq6ct9q0y
5 Jul 19
Therapix Biosciences Announces First Quarter 2019 Condensed Financial Data
6:08am
6-K
3x3ebteaxr6
18 Jun 19
Therapix Biosciences Announces Interim Results of Phase IIa Study at Assuta Medical Center for Obstructive Sleep Apnea Program
4:09pm
6-K
yujl1i2rl80rhbd
29 May 19
Therapix Biosciences Issues Shareholder Update Letter
4:05pm
6-K
zof4k89mfk3juj
23 May 19
Therapix Biosciences Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Non-Compliance
5:02pm
NT 20-F
lq3384tshws3t
1 May 19
Notice of late annual filing (foreign)
6:05am
D
pu0 589afcve6c
9 Apr 19
$2.25M in options, sold $2.25M, 8 investors
9:04am
424B5
vf2uc
1 Apr 19
Prospectus supplement for primary offering
6:57am
6-K
1dc37o hyq1m09ug40g5
28 Mar 19
Therapix Biosciences Announces Pricing
8:51am
6-K
2asp q7crf4m7j57uc
26 Mar 19
Report of Foreign Private Issuer
4:08pm
6-K
mv2at30lkpv1
19 Mar 19
Therapix Biosciences Appoints Ambassador Ron Prosor as Executive Advisor
8:04am
6-K
3hq3a3
13 Mar 19
Report of Foreign Private Issuer
4:02pm
6-K
valc mxv68
7 Mar 19
Report of Foreign Private Issuer
5:27pm
6-K
xydo362tn0h
12 Feb 19
The Cannabinoids of the Future
12:00am
6-K
jxaq3xmradagws
17 Jan 19
Annual General Meeting of Shareholders
4:05pm
6-K
5yb2hng4a8gspjhws
21 Dec 18
Report of Foreign Private Issuer
8:11am